NN Investment Partners Holdings’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

NN Investment Partners Holdings’s Portfolio TARO Stock Details TARO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-54,947	Closed	-$5.4M	–	731
2018 Q3	$5.4M	Buy	54,947 +5,057	+10%	+$547K	0.04%	286
2018 Q2	$5.77M	Sell	49,890 -353	-0.7%	-$38.8K	0.04%	268
2018 Q1	$4.96M	Buy	50,243 +1,182	+2%	+$120K	0.04%	318
2017 Q4	$5.14M	Sell	49,061 -4,915	-9%	-$540K	0.04%	309
2017 Q3	$6.05M	Hold	53,976	–	–	0.04%	305
2017 Q2	$6.05M	Buy	53,976 +1,064	+2%	+$120K	0.06%	228
2017 Q1	$6.17M	Sell	52,912 -842	-2%	-$93.2K	0.06%	223
2016 Q4	$5.66M	Sell	53,754 -2,395	-4%	-$251K	0.05%	228
2016 Q3	$6.21M	Buy	56,149 +56,049	+56,049%	+$7.42M	0.06%	220
2016 Q2	$15K	Hold	100	–	–	﹤0.01%	872
2016 Q1	$14K	Buy	+100	New	+$14.2K	﹤0.01%	874

Other funds holding TARO

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

AJO LP Philadelphia, Pennsylvania $199M AUM 109.68% 1-Year Est. Return

FCH

Freestone Capital Holdings Seattle, Washington $3.86B AUM 26.3% 1-Year Est. Return

NN Investment Partners Holdings's TARO Position: Q4 2018 in Review

NN Investment Partners Holdings sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q4 2018, closing a stake of 54,947 shares — an estimated $5.4M sold.

NN Investment Partners Holdings first reported a position in TARO in Q1 2016 and held it in 11 quarters. The position peaked at $6.21M in Q3 2016. 94 funds tracked by Wall St. Rank hold TARO as of Q4 2018.

NN Investment Partners Holdings reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q4 2018 after selling out during the quarter.
NN Investment Partners Holdings sold 54,947 Taro Pharmaceutical Industries Ltd. shares in Q4 2018, an estimated $5.4M.
NN Investment Partners Holdings first reported a position in Taro Pharmaceutical Industries Ltd. in Q1 2016 and held it in 11 quarters.
NN Investment Partners Holdings's Taro Pharmaceutical Industries Ltd. position peaked at $6.21M in Q3 2016.
94 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q4 2018.

Based on NN Investment Partners Holdings's 13F filing for Q4 2018, filed 14 Feb 2019.